Lynn Bjerke

2.3k total citations
8 papers, 505 citations indexed

About

Lynn Bjerke is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Lynn Bjerke has authored 8 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Oncology. Recurrent topics in Lynn Bjerke's work include Glioma Diagnosis and Treatment (4 papers), DNA Repair Mechanisms (2 papers) and PARP inhibition in cancer therapy (2 papers). Lynn Bjerke is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), DNA Repair Mechanisms (2 papers) and PARP inhibition in cancer therapy (2 papers). Lynn Bjerke collaborates with scholars based in United Kingdom, Australia and Portugal. Lynn Bjerke's co-authors include Paul Workman, Paul A. Clarke, Timothy A. Yap, Chris Jones, Diana Carvalho, Alan Mackay, Rui Manuel Reis, Alexa Jury, Sergey Popov and Christopher J. Lord and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Cancer Discovery.

In The Last Decade

Lynn Bjerke

8 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynn Bjerke United Kingdom	6	381	178	104	88	65	8	505
L. Adam United States	9	279 0.7×	153 0.9×	106 1.0×	213 2.4×	48 0.7×	10	544
Daniel Antunes Moreno Brazil	11	293 0.8×	82 0.5×	73 0.7×	87 1.0×	35 0.5×	34	461
Anja Kafka Croatia	13	315 0.8×	82 0.5×	125 1.2×	120 1.4×	63 1.0×	24	536
Daina Skiriutė Lithuania	14	279 0.7×	98 0.6×	118 1.1×	56 0.6×	19 0.3×	31	428
Kirsi J. Granberg Finland	12	255 0.7×	123 0.7×	111 1.1×	68 0.8×	18 0.3×	18	386
Katelyn N. Nelson United States	10	366 1.0×	82 0.5×	79 0.8×	95 1.1×	32 0.5×	14	488
Estelle Daudigeos‐Dubus France	11	161 0.4×	58 0.3×	72 0.7×	102 1.2×	90 1.4×	19	332
Alexandre Arcaro Switzerland	14	393 1.0×	60 0.3×	209 2.0×	195 2.2×	49 0.8×	20	606
Maria-Beatriz S. Lopes United States	8	131 0.3×	106 0.6×	52 0.5×	42 0.5×	83 1.3×	8	412
Tamalee Kramp United States	13	314 0.8×	120 0.7×	143 1.4×	148 1.7×	17 0.3×	25	534

Countries citing papers authored by Lynn Bjerke

Since Specialization

Citations

This map shows the geographic impact of Lynn Bjerke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Bjerke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Bjerke more than expected).

Fields of papers citing papers by Lynn Bjerke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Bjerke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Bjerke. The network helps show where Lynn Bjerke may publish in the future.

Co-authorship network of co-authors of Lynn Bjerke

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Bjerke. A scholar is included among the top collaborators of Lynn Bjerke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Bjerke. Lynn Bjerke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Bjerke, Lynn, Diana Carvalho, Jessica K.R. Boult, et al.. (2018). PDTM-33. ATRX LOSS CONFERS ENHANCED SENSITIVITY TO COMBINED PARP INHIBITION AND RADIOTHERAPY IN PAEDIATRIC GLIOBLASTOMA MODELS. Neuro-Oncology. 20(suppl_6). vi210–vi211. 4 indexed citations

2.

Vinci, Maria, Diana Carvalho, Helen N. Pemberton, et al.. (2017). Abstract 1932: Mutations in ATRX increase genetic instability and sensitivity to PARP inhibitors in paediatric glioblastoma cells. Cancer Research. 77(13_Supplement). 1932–1932. 2 indexed citations

3.

Yap, Timothy A., Lynn Bjerke, Paul A. Clarke, & Paul Workman. (2015). Drugging PI3K in cancer: refining targets and therapeutic strategies. Current Opinion in Pharmacology. 23. 98–107. 163 indexed citations

4.

Carvalho, Diana, Alan Mackay, Lynn Bjerke, et al.. (2014). The prognostic role of intragenic copy number breakpoints and identification of novel fusion genes in paediatric high grade glioma. Acta Neuropathologica Communications. 2(1). 23–23. 16 indexed citations

5.

Bjerke, Lynn, Alan Mackay, Meera Nandhabalan, et al.. (2013). Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN. Cancer Discovery. 3(5). 512–519. 226 indexed citations

6.

Hoff, Jana Midelfart, et al.. (2012). Trykksår etter ryggmargsskade. Tidsskrift for Den norske legeforening. 132(7). 838–839. 9 indexed citations

7.

Bielen, Aleksandra, Gary Box, Lara Perryman, et al.. (2012). Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition. Proceedings of the National Academy of Sciences. 109(20). E1267–76. 28 indexed citations

8.

Guillard, Sandrine, Paul A. Clarke, Robert te Poele, et al.. (2009). Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human glioma. Cell Cycle. 8(3). 443–453. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact